Ads
related to: can a nurse practitioner diagnose alzheimer's risk
Search results
Results From The WOW.Com Content Network
The biomarkers of Alzheimer's disease are neurochemical indicators used to assess the risk or presence of the disease. The biomarkers can be used to diagnose Alzheimer's disease (AD) in a very early stage, but they also provide objective and reliable measures of disease progress.
AGNPs can be found practicing in a variety of medical facilities including hospices, long-term care facilities, hospitals, home-based care, correctional institutes and primary practices. [4] The scope of practice varies from state to state because nurse practice laws and regulations are specific to the state the nurse practitioner practices in. [5]
A gerontological nurse specialist is an advanced practice nurse or nurse practitioner who has graduate education in gerontological nursing. Specific education in gerontological care is important for all nurses, even those who work outside of long-term care, because older adults make up a significant portion of patients across specialties. [40]
For premium support please call: 800-290-4726 more ways to reach us
The diagnosing phase involves a nurse making an educated judgement about a potential or actual health problem with a patient. Multiple diagnoses are sometimes made for a single patient. These assessments not only include a description of the problem or illness (e.g. sleep deprivation) but also whether or not a patient is at risk of developing ...
Alzheimer’s disease affects nearly 7 million people in the U.S. alone, according to the Alzheimer’s Association, and it is the most common type of dementia, making up an estimated 60% to 80% ...
There are a lot of aspects of Alzheimer’s disease that remain a mystery, but the Alzheimer’s Association says there are a few things you can do to lower your risk: Try to manage your blood ...
Similar to the NINCDS-ADRDA Alzheimer's Criteria are the DSM-IV-TR criteria published by the American Psychiatric Association. [3] At the same time the advances in functional neuroimaging techniques such as PET or SPECT that have already proven their utility to differentiate Alzheimer's disease from other possible causes, [4] have led to proposals of revision of the NINCDS-ADRDA criteria that ...